Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001104659-23-070813

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2023-06-06 Grant or award · Stock Option (Right to Buy) −25,000 25,000 I
Loading xslF345X04/tm2318619-1_4seq1.xml…